Back to GetFilings.com
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-Q
(Mark One)
(X) Quarterly Report Under Section 13 or 15(D) of The Securities Exchange
Act of 1934 For Quarter Ended September 30, 2003
OR
( ) Transition Report Pursuant to Section 13 or 15(d) of The Securities
Exchange Act of 1934
Commission File Number 0-275
Allen Organ Company
(Exact name of registrant as specified in its charter)
Pennsylvania 23-1263194
(State of Incorporation) (I.R.S. Employer Identification No.)
150 Locust Street, P. O. Box 36, Macungie, Pennsylvania 18062-0036
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 610-966-2200
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.
Yes X No
Indicate by check mark whether the registrant is an accelerated filer as
defined in Rule 12b-2 of the Exchange Act.
Yes No X
Number of shares outstanding of each of the issuer's classes of common
stock, as of November 6, 2003:
Class A - Voting 83,864 shares
Class B - Non-voting 1,072,381 shares
ALLEN ORGAN COMPANY
INDEX
Part I Financial Information
Item 1.Financial Statements
Consolidated Condensed Statements of Income for the three and
nine months ended September 30, 2003 and 2002
Consolidated Condensed Balance Sheets at September 30, 2003 and
December 31, 2002
Consolidated Condensed Statements of Cash Flows for the three
and nine months ended September 30, 2003 and 2002
Notes to Consolidated Condensed Financial Statements
Item 2.Management's Discussion and Analysis of Financial Condition and
Results of Operations
Item 3.Quantitative and Qualitative Disclosures About Market Risk
Item 4.Controls and Procedures
Part II Other Information
Item 6.Exhibits and Reports on Form 8-K
Signatures
Exhibits
PART I FINANCIAL INFORMATION
ITEM 1.FINANCIAL STATEMENTS
ALLEN ORGAN COMPANY AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF INCOME
(Unaudited)
For the 3 Months Ended: For the 9 Months Ended:
9/30/2003 9/30/2002 9/30/2003 9/30/2002
Net Sales $14,932,091 $15,705,708 $41,532,435 $49,086,929
Cost and Expenses
Costs of sales 8,344,016 9,950,064 24,446,579 29,544,274
Selling, general and
administrative 4,031,534 3,318,095 11,141,161 10,574,900
Research and
development 2,306,428 1,873,589 6,157,005 5,876,240
Total Costs and
Expenses 14,681,978 15,141,748 41,744,745 45,995,414
Income (Loss) from
Operations 250,113 563,960 (212,310) 3,091,515
Investment and Other
Income 81,810 190,402 264,527 436,020
Income Before Taxes 331,923 754,362 52,217 3,527,535
Income Tax Provision 131,000 226,000 21,000 1,058,000
Net Income $ 200,923 $ 528,362 $ 31,217 $ 2,469,535
Basic and Diluted
Earnings Per Share $0.17 $0.45 $0.03 $2.11
Weighted Average Shares
Used in Per Share
Calculation 1,161,269 1,170,235 1,161,269 1,170,235
Dividends Per Share-Cash $0.14 $0.14 $0.42 $0.42
Total Comprehensive
Income $ 195,671 $ 522,439 $ 29,553 $ 2,499,613
See accompanying notes.
ALLEN ORGAN COMPANY AND SUBSIDIARIES
CONSOLIDATED CONDENSED BALANCE SHEETS
Sept. 30, 2003 Dec. 31, 2002
ASSETS (Unaudited) (Audited)
Current Assets
Cash $ 4,732,805 $ 4,515,189
Investments Including Accrued Interest 17,338,637 17,176,750
Accounts Receivable, net of reserves of
$573,434 and $502,209, respectively 9,252,892 12,184,564
Inventories:
Raw Materials 5,176,844 5,451,664
Work in Process 5,468,917 5,707,215
Finished Goods 3,868,192 5,064,803
Total Inventories 14,513,953 16,223,682
Prepaid Income Taxes -- 161,071
Prepaid Expenses 322,380 318,943
Deferred Income Taxes 1,998,489 1,992,694
Total Current Assets 48,159,156 52,572,893
Property, Plant and Equipment 27,862,726 27,328,631
Less Accumulated Depreciation (17,644,804) (16,471,137)
Net Property, Plant and Equipment 10,217,922 10,857,494
Other Assets
Note Receivable from Related Party 2,397,291 2,397,291
Cash Value of Life Insurance 2,306,463 2,273,163
Deferred Income Taxes 3,422,448 3,422,448
Intangible Assets, net 1,287,740 1,628,964
Goodwill, net 194,523 194,523
Other Assets 15,000 16,092
Total Other Assets 9,623,465 9,932,481
Total Assets $68,000,543 $73,362,868
LIABILITIES AND STOCKHOLDERS' EQUITY
LIABILITIES
Current Liabilities
Accounts Payable $ 874,730 $ 5,688,967
Accrued Expenses 3,053,467 2,638,258
Accrued income taxes 46,366 --
Customer Deposits 2,484,219 2,693,980
Total Current Liabilities 6,458,782 11,021,205
Noncurrent Liabilities
Deferred and Other Noncurrent Liabilities 1,351,483 1,028,785
Accrued Pension Costs 4,842,781 5,006,546
Total Noncurrent Liabilities 6,194,264 6,035,331
Total Liabilities 12,653,046 17,056,536
STOCKHOLDERS' EQUITY
Common Stock 2003 2002
Class A 127,232 shares; 127,232 shares 127,232 127,232
Class B 1,410,761 shares; 1,410,761 shares 1,410,761 1,410,761
Capital in Excess of Par Value 12,961,610 12,961,610
Retained Earnings
Balance, Beginning 57,267,763 55,237,713
Net Income 31,217 2,685,357
Dividends - Cash 2003 and 2002 (487,645) (655,307)
Balance, End 56,811,335 57,267,763
Accumulated Other Comprehensive Loss (3,471,057) (3,460,463)
Sub-total 67,839,881 68,306,903
Treasury Stock
2003 - 43,368 Class A shares;
338,065 Class B shares (12,492,384) --
2002 - 43,368 Class A shares;
324,565 Class B shares -- (12,000,571)
Total Stockholders' Equity 55,347,497 56,306,332
Total Liabilities and Stockholders' Equity $68,000,543 $73,362,868
See accompanying notes.
ALLEN ORGAN COMPANY AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)
For the 3 Months Ended: For the 9 Months Ended:
9/30/2003 9/30/2002 9/30/2003 9/30/2002
CASH FLOWS FROM OPERATING
ACTIVITIES
Net income $200,923 $528,362 $31,217 $2,469,535
Adjustments to reconcile net
income to net cash (used in)
provided by operating activities
Depreciation and amortization 628,206 691,750 1,848,995 2,111,205
Deferred income taxes (3,776) (2,323) (5,795) 16,708
Change in assets and liabilities
Accounts receivable (3,299,996) 1,876,816 2,931,672 2,128,316
Inventories 936,201 470,815 1,709,729 959,815
Income taxes prepaid and
receivable 79,825 810,699 161,071 531,921
Prepaid expenses 249,899 108,820 (3,437) (55,173)
Other assets -- -- 1,092 --
Accounts payable 111,016 (216,733) (4,814,237) (382,538)
Accrued expenses 398,731 315,319 415,209 740,316
Accrued income taxes 46,366 -- 46,366 --
Customer deposits (5,956) (37,721) (209,761) 31,518
Accrued pension costs 308,118 169,242 (163,765) 342,685
Deferred and other noncurrent
liabilities 79,066 46,371 322,698 139,090
Net Cash (Used In) Provided
by Operating Activities (271,377) 4,761,417 2,271,054 9,033,398
CASH FLOW FROM INVESTING ACTIVITIES
Increase in note receivable -- -- -- (400,184)
Net additions to plant and
equipment (342,680) (566,046) (711,342) (1,513,296)
Additions to intangible assets (85,991) (27,000) (273,761) (29,780)
Increase in cash value of life
insurance (33,300) (40,416) (33,300) (40,416)
Net purchase of short term
investments (45,703) (7,348,328) (172,481) (5,552,630)
Net Cash Used In Investing
Activities (507,674) (7,981,790) (1,190,884) (7,536,306)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from sales of
subsidiary stock 1,305 15,927 123,905 17,967
Repurchase of subsidiary stock (7,001) -- (7,001) --
Reacquired Class B common
shares -- (10,570) (491,813) (10,570)
Dividends paid in cash (161,918) (163,808) (487,645) (491,498)
Net Cash Used In Financing
Activities (167,614) (158,451) (862,554) (484,101)
NET (DECREASE) INCREASE IN CASH (946,665) (3,378,824) 217,616 1,012,991
CASH, BEGINNING 5,679,470 8,841,813 4,515,189 4,449,998
CASH, ENDING $4,732,805 $5,462,989 $4,732,805 $5,462,989
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION
Cash paid (refunded) for:
Income Taxes $ 4,809 $ (584,699) $ (189,437) $ 526,079
Interest $ -- $ -- $ -- $ --
See accompanying notes.
ALLEN ORGAN COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
1. Interim Financial Statements
The results of operations for the interim periods presented in this
report are not necessarily indicative of results to be expected for the
fiscal year. In the opinion of management, the information contained
herein reflects all adjustments necessary for a fair presentation of
the Company's financial position, results of operations and cash flows
for these interim periods. All such adjustments are of a normal
recurring nature.
Certain notes and other information have been condensed or omitted from
the interim financial statements presented in the Quarterly Report on
Form 10-Q. Therefore, these financial statements should be read in
conjunction with the Company's 2002 Annual Report on Form 10-K.
2. Stock-Based Compensation
The Company accounts for its stock-based compensation plans using the
accounting prescribed by Accounting Principles Board Opinion No. 25,
"Accounting for Stock Issued to Employees". Since the Company is not
required to adopt the fair value based recognition provisions
prescribed under Statement of Financial Accounting Standards No. 123,
as amended by SFAS No. 148, "Accounting for Stock-Based Compensation",
it has elected only to comply with the disclosure requirements set
forth in the Statements.
Had compensation cost been determined on the basis of fair value
pursuant to SFAS No. 123, as amended by SFAS No. 148, net income and
earnings per share would have been decreased as follows:
Three Months Ended Nine Months Ended
September 30, September 30,
2003 2002 2003 2002
Net income
As Reported $200,923 $528,362 $ 31,217 $2,469,535
Total stock-based
employee compensation
benefit (expense)
determined under fair
value based method for
all awards, net of
related tax effects 11,790 (17,344) 35,370 (52,031)
Pro forma $212,713 $511,018 $ 66,587 $2,417,504
Earnings per share
As reported $ 0.17 $ 0.45 $ 0.03 $ 2.11
Pro forma $ 0.18 $ 0.44 $ 0.06 $ 2.07
The fair value of each option granted is estimated on the grant date
using the Black-Scholes option pricing model. The following
assumptions were made in estimating the fair value of options when
granted under the Allen Organ Company stock option plan:
Assumptions
Dividend yield 1.40%
Risk-free interest rate 2.50%
Expected life 7 years
Expected volatility 10%
No stock options were granted to employees during the three and nine
months ended September 30, 2003.
3. Warranty Costs
The Company provides a warranty covering manufacturing defects for
certain of its products for varying lengths of time. The Company's
policy is to accrue the estimated cost of warranty coverage at the time
the sale is recorded. The activity in the warranty accrual during the
nine months ended September 30, 2003 is summarized as follows:
Accrual at January 1, 2003 $ 300,000
Additions charged to warranty expense 91,329
Claims paid and charged against the accrual (46,329)
Accrual at September 30, 2003 $ 345,000
4. Earnings Per Share
Outstanding stock options were not included in computing earnings per
share because their effect was antidilutive as the exercise price of
the options was above the average trading price of the underlying
stock. Options excluded were 12,000 for the three and nine months
ended September 30, 2003 at a weighted average exercise price of $39.00
per share.
5. Business Acquisition
On July 24, 2003, the Company's subsidiary, Eastern Research, Inc.
(ERI), purchased the assets of Avail Networks, Inc. (Avail) in exchange
for $200,000 in cash and contingent payments based on future revenue
related to the sale of Avail products during the 30 months after the
acquisition.
Avail's intelligent last-mile broadband solutions enable service
providers worldwide to deliver more revenue-generating services to
their enterprise customers from a single customer located platform
across metro fiber, traditional wireline and wireless access networks.
Avail's flagship FronteraT products deliver multiple services to end-
user sites in a variety of subscriber locations and configurations.
The acquisition of Avail reinforces ERI's commitment to the access
network market. With the addition of the Frontera products to its
existing product offerings, ERI is positioned as a supplier of network
access solutions for next-generation convergence applications, such as
integrated data, voice and video over single broadband connections. In
addition, this acquisition gives ERI access to Avail's advanced ATM
(Asynchronous Transmission Mode) technology.
Avail's sales prior to the acquisition date were minimal. With the
Frontera products ready for production, ERI will introduce them to
their established customer base. Due to lengthy sales cycles, these
products are not expected to add significant revenues in the near-term.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND
RESULTS OF OPERATIONS.
Liquidity and Capital Resources:
Cash flows from operating activities during the three months ended
September 30, 2003 were lower than the same period in 2002 due to lower net
income and an increase in accounts receivable in the Data Communications
segment. Cash flow from operating activities during the nine months ended
September 30, 2003 decreased when compared to the same period in 2002
primarily due to lower net income and a greater reduction in accounts
payable in the Data Communications segment from the payment in early 2003
of inventory purchased to fulfill a large customer order in the fourth
quarter of 2002.
Cash flows from investing activities of approximately $700,000 were used
to purchase property and equipment during the nine months ended September
30, 2003 primarily in the Data Communications segment.
Cash flows from financing activities of approximately $490,000 were used
to reacquire shares of the Company's Class B stock and another $487,000 was
used to pay dividends during the nine months ended September 30, 2003.
Results of Operations:
Sales and Operating Income
For the 3 Months Ended: For the 9 Months Ended:
9/30/2003 9/30/2002 9/30/2003 9/30/2002
Net Sales to
Unaffiliated Customers
Musical Instruments $ 5,017,156 $ 5,778,976 $15,207,450 $18,701,819
Data Communications 9,024,930 8,130,042 23,066,883 25,654,556
Electronic Assemblies 531,546 1,486,132 2,060,690 3,582,948
Audio Equipment 358,459 310,558 1,197,412 1,147,606
Total $14,932,091 $15,705,708 $41,532,435 $49,086,929
Intersegment Sales
Musical Instruments $ 190,941 $ 133,553 $ 604,650 $ 298,699
Data Communications -- -- -- --
Electronic Assemblies 64,818 49,063 64,818 131,540
Audio Equipment 38,547 13,151 74,586 71,385
Total $ 294,306 $ 195,767 $ 744,054 $ 501,624
Income (Loss) from Operations
Musical Instruments $ (107,030) $ 154,023 $ (621,419) $ 1,799,900
Data Communications 553,002 525,480 1,106,261 1,997,708
Electronic Assemblies (115,688) 50,254 (525,144) (298,208)
Audio Equipment (80,171) (165,797) (172,008) (407,885)
Total $ 250,113 $ 563,960 $ (212,310) $ 3,091,515
Musical Instruments Segment
Sales decreased $761,820 and $3,494,369, for the three and nine months
ended September 30, 2003, respectively, when compared to the same periods
in 2002 due to lower order volume, which management believes is
attributable to the overall economic slowdown. Sales for the first nine
months of 2002 were also higher due to the shipment of organs from the
order backlog, which was higher at the beginning of 2002 than at the
beginning of 2003.
The gross profit percentage was 23.2% for both the three months ended
September 30, 2003 and 2002 and 21.6% in the nine months ended September
30, 2003 compared to 30.1% in the same period of 2002. This decrease is
due to lower sales volume over which to absorb fixed costs and higher
operating costs including employee pension expense. The Company has taken
steps to reduce its operating costs at the Macungie, PA plant, including
reductions in personnel.
Selling, general and administrative and research and development
expenses increased slightly during the three and nine months ended
September 30, 2003, when compared to the same periods in 2002 due primarily
to higher pension expense.
Data Communications Segment
Sales increased $894,888 during the three months ended September 30,
2003 and decreased $2,587,673 during the nine months ended September 30,
2003, when compared to the same periods in 2002. The increase during the
third quarter of 2003 is due to higher order volume. The decrease during
the first half of 2003 was attributable to economic weakness in the data
communications market and the timing of completing sales with larger
customers.
Gross profit margins increased to 58.6% and 58.5%, during the three and
nine months ended September 30, 2003, respectively, from 51.3% and 52.8%.
These increases are primarily related to favorable product mix and
reductions in product cost. The margin for the nine months ended September
30, 2003 includes $1,400,000 of revenue recognized on product software
development for a customer during the second quarter of 2003. Excluding
this item, gross margins for the nine months ended September 30, 2003 were
55.8%.
Sales and marketing expenditures increased approximately $528,000 (34%)
and $563,000 (12%) during the three and nine months ended September 30,
2003, respectively, when compared to the same periods in 2002. These
increases are primarily related to personnel added in connection with the
acquisition of Avail Networks discussed in Note 5 above.
General and administrative expenditures increased approximately $173,000
(29%) and $188,000 (10%) during the three and nine months ended September
30, 2003, respectively, when compared to the same periods in 2002. These
increases are primarily related to additional personnel and other cost
incurred in connection with the acquisition of Avail Networks.
Research and development expenses increased approximately $443,000 (30%)
and $130,000 (3%), respectively, during the three and nine months ended
September 30, 2003, when compared to the same periods in 2002. These
increases are also primarily related to additional personnel added in
connection with the acquisition of Avail Networks.
While the telecommunications market has begun to show signs of
stabilizing, the overall business visibility remains limited. This segment
continues to be successful in a challenging market due to new customer and
market penetration. Future performance will be affected by the Company's
ability to continue to expand its market share. Given this, and the
overall market stabilization, the Company has begun to invest in research
and development of next generation technologies. This will increase the
segment's research and development expense in future quarters. In
addition, future gross margins could be impacted by changes in product mix.
Certain data communications companies continue to lower their capital
expenditure spending. This along with continued uncertainty in completing
sales to larger accounts, create significant uncertainty for operating
results in future quarters.
Electronic Assemblies Segment
Sales decreased $954,586 and $1,522,258, for the three and nine months
ended September 30, 2003, respectively, when compared to the same periods
in 2002 due to lower order volume from the Company's contract manufacturing
customers who have been affected by the economic slowdown. This segment is
focused on diversifying its customer base and has been successful in
obtaining new customers. The potential sales significance of these new
accounts cannot be determined at this time.
The gross profit margin was a loss of approximately 6% and 13%, for the
three and nine months ended September 30, 2003, respectively, compared to a
gross margin of 9% for the three months ended September 30, 2002 and a loss
of approximately 1% during the nine months ended September 30, 2002. The
2003 losses are primarily due to lower sales volume over which to absorb
fixed costs. Selling, general and administrative expenses during the three
and nine months ended September 30, 2003 were approximately equal to the
same periods in 2002. The Company has taken steps to reduce its operating
costs at the Macungie, PA plant including reductions in personnel.
Audio Equipment Segment
Sales for the three and nine months ended September 30, 2003 increased
slightly when compared to the same periods in 2002. Legacy Audio remains
focused on developing a quality independent dealer network of high end
audio-video stores and custom installers.
Gross profit margins were 31% and 35%, in the three and nine months
ended September 30, 2003, respectively, as compared to 23% and 24% in the
same periods in 2002 primarily due to lower operating costs related to the
closure of the Springfield, IL plant and consolidation of all production
into the Macungie, PA plant.
Selling, general and administrative costs for the period decreased
during the three and nine months ended September 30, 2003 when compared to
the same periods in 2002.
Other Income and Expense
Investment income decreased during the three and nine months ended
September 30, 2003 when compared to the same periods in 2002 due to lower
rates of return available on invested funds.
Income Taxes
The tax provision for the three and nine months ended September 30, 2003
are based on the estimated effective tax rate for the year.
Contractual Obligations and Commercial Commitments
During the nine months ended September 30, 2003, there have been no items
that significantly impacted the Company's commitments and contingencies as
disclosed in the notes to the 2002 consolidated financial statements as
filed on Form 10-K. In addition, the Company has no significant off
balance sheet arrangements.
Factors that May Affect Operating Results
The statements contained in this report on Form 10-Q that are not purely
historical are forward looking statements within the meaning of Section 27A
of the Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934, including statements regarding the Company's expectations,
hopes, intentions or strategies regarding the future. Forward looking
statements include: statements regarding future products or product
development; statements regarding future research and development spending
and the Company's marketing and product development strategy, statements
regarding future production capacity. All forward looking statements
included in this document are based on information available to the Company
on the date hereof, and the Company assumes no obligation to update any
such forward looking statements. Readers are cautioned not to place undue
reliance on these forward looking statements, which reflect management's
opinions only as of the date hereof. Readers should carefully review the
risk factors described in other documents the Company files from time to
time with the Securities and Exchange Commission, including the Annual
Report on Form 10-K. It is important to note that the Company's actual
results could differ materially from those in such forward looking
statements. Some of the factors that could cause actual results to differ
materially are set forth below.
The Company has experienced and expects to continue to experience
fluctuations in its results of operations. Factors that affect the
Company's results of operations include the volume and timing of orders
received, changes in global economics and financial markets, changes in the
mix of products sold, market acceptance of the Company's and its customer's
products, competitive pricing pressures, global currency valuations, the
availability of electronic components that the Company purchases from
suppliers, the Company's ability to meet increasing demand, the Company's
ability to introduce new products on a timely basis, the timing of new
product announcements and introductions by the Company or its competitors,
changing customer requirements, delays in new product qualifications, the
timing and extent of research and development expenses and fluctuations in
manufacturing yields. As a result of the foregoing or other factors, there
can be no assurance that the Company will not experience material
fluctuations in future operating results on a quarterly or annual basis,
which would materially and adversely affect the Company's business,
financial condition and results of operations.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
No change from information disclosed in the Company's 2002 annual
report on Form 10-K.
ITEM 4. CONTROLS AND PROCEDURES.
The Company's Chief Executive Officer and Chief Financial Officer have
evaluated the effectiveness of the design and operation of the
Company's disclosure controls and procedures, which are designed to
insure that the Company records, processes, summarizes and reports in a
timely and effective manner the information required to be disclosed in
the reports filed with or submitted to the Securities and Exchange
Commission. Based upon this evaluation, they concluded that the
Company's disclosure controls are effective as of September 30, 2003.
There has been no change in the Company's internal control over
financial reporting that occurred during the quarter ended September
30, 2003 that has materially affected, or is reasonably likely to
materially affect, the Company's internal control over financial
reporting.
PART II OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits
Exhibit No. Description
31.1 Rule 13a-14(a)/15d-14(a) Certification - Chief Executive
Officer
31.2 Rule 13a-14(a)/15d-14(a) Certification - Chief Financial
Officer
32 Section 1350 Certifications
(b) Form 8-K
1.The Company filed a Form 8-K dated July 24, 2003
announcing that its subsidiary Eastern Research, Inc. had
acquired the assets of privately-held Avail Networks, Inc of
Ann Arbor, Michigan.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Allen Organ Company
(Registrant)
Date:November 6, 2003 /s/STEVEN MARKOWITZ
Steven Markowitz, President and Chief Executive
Officer
Date:November 6, 2003 /s/NATHAN S. ECKHART
Nathan S. Eckhart, Vice President-Finance,
Chief Financial and Principal Accounting
Officer